Prescription Drug Marketing Act

Results: 65



#Item
1CONTINUING CONCERNS OVER IMPORTED PHARMACEUTICALS HEARING BEFORE THE

CONTINUING CONCERNS OVER IMPORTED PHARMACEUTICALS HEARING BEFORE THE

Add to Reading List

Source URL: house.resource.org

Language: English - Date: 2010-10-22 14:00:55
2Guidance for Industry Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.

Guidance for Industry Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.

Add to Reading List

Source URL: www.fda.gov

Language: English
3RepliGen   Sandford D. Smith President and Chief Executive 01ficer  Repligen Corporation

RepliGen Sandford D. Smith President and Chief Executive 01ficer Repligen Corporation

Add to Reading List

Source URL: www.clintonlibrary.gov

Language: English - Date: 2014-06-13 22:34:43
4United States Government Accountability Office  GAO Report to Congressional Requesters

United States Government Accountability Office GAO Report to Congressional Requesters

Add to Reading List

Source URL: pharmwatch.org

Language: English - Date: 2007-02-14 06:08:54
5Microsoft Word - Stat_Controlled Substances and Legend Drugs.doc

Microsoft Word - Stat_Controlled Substances and Legend Drugs.doc

Add to Reading List

Source URL: pharmacyboard.arkansas.gov

Language: English - Date: 2014-09-05 17:19:18
6Guidance for Industry Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees

Guidance for Industry Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees

Add to Reading List

Source URL: www.fda.gov

Language: English
7Health / Pharmacology / Pharmaceutical industry / Marketing / Clinical pharmacology / Prescription Drug Marketing Act / Title 21 CFR Part 11 / Prescription medication / Food and Drug Administration / Pharmaceuticals policy / Pharmaceutical sciences / Medicine

DOC Document

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2003-09-17 11:18:13
8725 15th Street, NW 4 Suite 700 b Washington, DC[removed][removed]l-888-USBLOOD 4 FAX[removed]WebSite:http://www.americasblood.org 4 e-mail:[removed] October 6,200O Docket No. 92N-0297 Dockets Mana

725 15th Street, NW 4 Suite 700 b Washington, DC[removed][removed]l-888-USBLOOD 4 FAX[removed]WebSite:http://www.americasblood.org 4 e-mail:[removed] October 6,200O Docket No. 92N-0297 Dockets Mana

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2000-10-26 12:14:21
9International Academy of Compounding Pharmacists P.O. Box 1365 Sugar Land, Texas[removed]

International Academy of Compounding Pharmacists P.O. Box 1365 Sugar Land, Texas[removed]

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2000-10-26 13:06:12
10Pharmaceutical  Statement of the Research and Manufacturers  of America

Pharmaceutical Statement of the Research and Manufacturers of America

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2000-11-16 00:49:41